Neovacs S.A. (EPA:ALNEV)
0.7700
+0.0400 (5.48%)
Aug 3, 2026, 5:35 PM CET
Neovacs Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.57 | 0.44 | 0.89 | 0.04 | 16.25 |
Short-Term Investments | 0 | 0 | 0 | 6.72 | 16.84 |
Cash & Short-Term Investments | 0.57 | 0.44 | 0.89 | 6.76 | 33.09 |
Cash Growth | 31.31% | -50.91% | -86.87% | -79.57% | 228.45% |
Accounts Receivable | 0.41 | 0.31 | 0.57 | 0.01 | 0.01 |
Other Receivables | 1.55 | 1.65 | 2.21 | 1.8 | 1.59 |
Total Trade Receivables | 1.95 | 1.95 | 2.78 | 1.81 | 1.6 |
Other Current Assets | 0.14 | 0.12 | 0.17 | 0.53 | 0.09 |
Total Current Assets | 2.63 | 2.46 | 3.84 | 9.1 | 34.78 |
Net Property, Plant & Equipment | 0.24 | 0.41 | 0.53 | 0.51 | 0.51 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 18.64 | 18.68 | 41.49 | 42.33 | 13.2 |
Other Long-Term Assets | 0.62 | 0.47 | 6.71 | 3.36 | 0.07 |
Total Assets | 22.17 | 22.07 | 52.56 | 55.29 | 48.55 |
Accounts Payable | 1.87 | 2.28 | 1.98 | 1.93 | 1.32 |
Accrued Expenses | 0.71 | 1.29 | 0.98 | 1.4 | 0.83 |
Other Current Liabilities | 0.03 | 0.05 | 0.1 | 0.12 | 0.15 |
Total Current Liabilities | 2.61 | 3.61 | 3.06 | 3.45 | 2.29 |
Long-Term Debt | 0.54 | 0.23 | 0.65 | 1.2 | 1.03 |
Other Long-Term Liabilities | 0.96 | 0.17 | 0.01 | 0.47 | 1.32 |
Total Long-Term Liabilities | 1.5 | 0.4 | 0.66 | 1.68 | 2.36 |
Total Liabilities | 3.15 | 3.84 | 3.71 | 5.12 | 4.65 |
Common Stock | 0.19 | 0.17 | 0.35 | 0.12 | 1.99 |
Additional Paid-in Capital | 79.44 | 77.57 | 141.78 | 139.67 | 135.12 |
Retained Earnings | -61.57 | -60.34 | -94.6 | -89.63 | -93.22 |
Total Common Shareholders' Equity | 18.06 | 17.41 | 47.53 | 50.17 | 43.9 |
Minority Interest | - | 0.65 | 1.31 | 0 | - |
Shareholders' Equity | 18.06 | 17.41 | 48.84 | 50.17 | 43.9 |
Total Liabilities & Equity | 22.17 | 22.07 | 52.56 | 55.29 | 48.55 |
Total Debt | 0.54 | 0.23 | 0.65 | 1.2 | 1.03 |
Net Cash (Debt) | 0.03 | 0.21 | 0.24 | 5.55 | 32.06 |
Net Cash Growth | -83.31% | -13.29% | -95.74% | -82.67% | 231.12% |
Net Cash Per Share | - | - | 0.67 | 82.27 | 474.76 |
Book Value | 18.06 | 17.41 | 47.53 | 50.17 | 43.9 |
Book Value Per Share | - | - | 135.15 | 742.99 | 650.19 |
Tangible Book Value | 18.06 | 17.41 | 47.53 | 50.16 | 43.9 |
Tangible Book Value Per Share | - | - | 135.15 | 742.95 | 650.17 |